メインナビゲーションにスキップ 検索にスキップ メインコンテンツにスキップ

Prospective analysis of oncogenic driver mutations and environmental factors: Japan molecular epidemiology for lung cancer study

  • Tomoya Kawaguchi
  • , Yasuhiro Koh
  • , Masahiko Ando
  • , Norimasa Ito
  • , Sadanori Takeo
  • , Hirofumi Adachi
  • , Tsutomu Tagawa
  • , Seiichi Kakegawa
  • , Motohiro Yamashita
  • , Kazuhiko Kataoka
  • , Yukito Ichinose
  • , Yukiyasu Takeuchi
  • , Masakuni Serizawa
  • , Akihiro Tamiya
  • , Shigeki Shimizu
  • , Naoki Yoshimoto
  • , Akihito Kubo
  • , Shun Ichi Isa
  • , Hideo Saka
  • , Akihide Matsumura

研究成果: ジャーナルへの寄稿学術論文査読

抄録

Purpose Oncogenic driver mutations are critical for lung cancer development and serve as therapeutic targets. However, their associations with environmental factors are not fully understood. We aimed to elucidate the relationship between tumor developmental biology and exposure to environmental factors. Patients and Methods This was a prospective, multicenter, molecular epidemiology study. Eligible patients were those with newly diagnosed stages I to IIIB non-small-cell lung cancer (NSCLC) who underwent surgery. The tumors were examined for somatic mutations in 72 cancer-associated genes by targeted deep sequencing, estrogen receptorβ (ERβ) expression using immunohistochemical staining, and infection with any of 37 types of human papillomavirus (HPV) using a polymerase chain reaction-based microarray system. Detailed information on patient demographics and environmental factors was obtained from a comprehensive questionnaire. Results From July 2012 to December 2013, 957 patients were enrolled, and molecular analyses were performed on 876 samples (from 441 ever- and 435 never-smokers). Oncogenic driver mutations in P53 and KRAS increased proportionally with smoking status, whereas mutations in EGFR and SMAD4 decreased. KRAS mutations in smokers and SMAD4 mutations were observed more frequently in proportion to body mass index. TP53 and NFE2L2 mutations were observed more frequently in advanced NSCLC stages. As for never-smokers, no environmental factors were significantly associated with mutational changes. EGFR mutations and TP53 mutations were observed more frequently in women and in men, respectively. Mutations in these two genes were also potentially associated with ERβ expression. Only three patients (0.3%) were HPV positive. Conclusion The mutational spectrum is associated with smoking, body mass index, and other environmental factors, as well as with ERβ expression. Little association was observed between HPV and NSCLC.

本文言語英語
ページ(範囲)2247-2257
ページ数11
ジャーナルJournal of Clinical Oncology
34
19
DOI
出版ステータス出版済み - 01-07-2016
外部発表はい

UN SDG

この成果は、次の持続可能な開発目標に貢献しています

  1. SDG 3 - すべての人に健康と福祉を
    SDG 3 すべての人に健康と福祉を

All Science Journal Classification (ASJC) codes

  • 腫瘍学
  • 癌研究

フィンガープリント

「Prospective analysis of oncogenic driver mutations and environmental factors: Japan molecular epidemiology for lung cancer study」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル